Applied Genetic Technologies (AGTC) Misses Q3 EPS by 4c

Applied Genetic Technologies (NASDAQ: AGTC) reported Q3 EPS of ($0.45), $0.04 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $5.57 million.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
• SuperCom (SPCB) Tops Q3 EPS by 43c